Search by Drug Name or NDC
NDC 24979-0538-10 Guanfacine 4 mg/1 Details
Guanfacine 4 mg/1
Guanfacine is a ORAL TABLET, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by TWi Pharmaceuticals, Inc.. The primary component is GUANFACINE.
Product Information
| NDC | 24979-0538 |
|---|---|
| Product ID | 24979-538_7e49ee6b-0131-49cd-bc67-6889ce4c90f0 |
| Associated GPIs | 61353030107550 |
| GCN Sequence Number | 065574 |
| GCN Sequence Number Description | guanfacine HCl TAB ER 24H 4 MG ORAL |
| HIC3 | H8M |
| HIC3 Description | TX FOR ADHD - SELECTIVE ALPHA-2 RECEPTOR AGONIST |
| GCN | 27582 |
| HICL Sequence Number | 000120 |
| HICL Sequence Number Description | GUANFACINE HCL |
| Brand/Generic | Generic |
| Proprietary Name | Guanfacine |
| Proprietary Name Suffix | Extended-Release |
| Non-Proprietary Name | Guanfacine |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, EXTENDED RELEASE |
| Route | ORAL |
| Active Ingredient Strength | 4 |
| Active Ingredient Units | mg/1 |
| Substance Name | GUANFACINE |
| Labeler Name | TWi Pharmaceuticals, Inc. |
| Pharmaceutical Class | Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA201408 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 24979-0538-10 (24979053810)
| NDC Package Code | 24979-538-10 |
|---|---|
| Billing NDC | 24979053810 |
| Package | 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (24979-538-10) |
| Marketing Start Date | 2017-07-07 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |